McBride Valuation
Is MCBL undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
5/6Valuation Score 5/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of MCBL when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: MCBL (£1.04) is trading below our estimate of fair value (£2.39)
Significantly Below Fair Value: MCBL is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for MCBL?
Key metric: As MCBL is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
What is MCBL's PE Ratio? | |
---|---|
PE Ratio | 5.4x |
Earnings | UK£33.30m |
Market Cap | UK£181.02m |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 0.3x |
Enterprise Value/EBITDA | 3.8x |
PEG Ratio | -32.1x |
Price to Earnings Ratio vs Peers
How does MCBL's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 35x | ||
RKT Reckitt Benckiser Group | 21.4x | 11.3% | UK£33.0b |
APN Applied Nutrition | 25.5x | n/a | UK£347.5m |
W7L Warpaint London | 24x | 11.8% | UK£410.5m |
VLG Venture Life Group | 69.3x | 67.1% | UK£51.5m |
MCBL McBride | 5.4x | -0.2% | UK£181.0m |
Price-To-Earnings vs Peers: MCBL is good value based on its Price-To-Earnings Ratio (5.4x) compared to the peer average (35x).
Price to Earnings Ratio vs Industry
How does MCBL's PE Ratio compare vs other companies in the Global Household Products Industry?
2 Companies | Price / Earnings | Estimated Growth | Market Cap |
---|---|---|---|
2 Companies | Estimated Growth | Market Cap | |
---|---|---|---|
Price-To-Earnings vs Industry: MCBL is good value based on its Price-To-Earnings Ratio (5.4x) compared to the Global Household Products industry average (17.2x).
Price to Earnings Ratio vs Fair Ratio
What is MCBL's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 5.4x |
Fair PE Ratio | 10.4x |
Price-To-Earnings vs Fair Ratio: MCBL is good value based on its Price-To-Earnings Ratio (5.4x) compared to the estimated Fair Price-To-Earnings Ratio (10.4x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | UK£1.04 | UK£1.67 +60.6% | 4.8% | UK£1.75 | UK£1.59 | n/a | 2 |
Nov ’25 | UK£1.15 | UK£1.67 +45.9% | 4.8% | UK£1.75 | UK£1.59 | n/a | 2 |
Oct ’25 | UK£1.20 | UK£1.67 +39.7% | 4.8% | UK£1.75 | UK£1.59 | n/a | 2 |
Sep ’25 | UK£1.32 | UK£1.67 +26.5% | 4.8% | UK£1.75 | UK£1.59 | n/a | 2 |
Aug ’25 | UK£1.31 | UK£1.67 +27.5% | 4.8% | UK£1.75 | UK£1.59 | n/a | 2 |
Jul ’25 | UK£1.39 | UK£1.29 -7.2% | 1.2% | UK£1.30 | UK£1.27 | n/a | 2 |
Jun ’25 | UK£1.23 | UK£1.29 +4.5% | 1.2% | UK£1.30 | UK£1.27 | n/a | 2 |
May ’25 | UK£1.07 | UK£1.29 +20.7% | 1.2% | UK£1.30 | UK£1.27 | n/a | 2 |
Apr ’25 | UK£0.99 | UK£1.16 +16.7% | 3.4% | UK£1.20 | UK£1.12 | n/a | 2 |
Mar ’25 | UK£0.89 | UK£1.16 +30.3% | 3.4% | UK£1.20 | UK£1.12 | n/a | 2 |
Feb ’25 | UK£0.71 | UK£1.04 +45.7% | 3.8% | UK£1.08 | UK£1.00 | n/a | 2 |
Jan ’25 | UK£0.80 | UK£0.86 +7.5% | 16.3% | UK£1.00 | UK£0.72 | n/a | 2 |
Dec ’24 | UK£0.71 | UK£0.86 +21.1% | 16.3% | UK£1.00 | UK£0.72 | n/a | 2 |
Nov ’24 | UK£0.42 | UK£0.72 +71.8% | 17.2% | UK£0.85 | UK£0.60 | UK£1.15 | 2 |
Oct ’24 | UK£0.39 | UK£0.45 +14.2% | 11.1% | UK£0.50 | UK£0.40 | UK£1.20 | 2 |
Sep ’24 | UK£0.38 | UK£0.38 -1.3% | 6.7% | UK£0.40 | UK£0.35 | UK£1.32 | 2 |
Aug ’24 | UK£0.38 | UK£0.38 0% | 6.7% | UK£0.40 | UK£0.35 | UK£1.31 | 2 |
Jul ’24 | UK£0.26 | UK£0.38 +44.2% | 6.7% | UK£0.40 | UK£0.35 | UK£1.39 | 2 |
Jun ’24 | n/a | UK£0.38 0% | 6.7% | UK£0.40 | UK£0.35 | UK£1.23 | 2 |
May ’24 | UK£0.31 | UK£0.38 +22.1% | 6.7% | UK£0.40 | UK£0.35 | UK£1.07 | 2 |
Apr ’24 | UK£0.27 | UK£0.35 +28.2% | 14.3% | UK£0.40 | UK£0.30 | UK£0.99 | 2 |
Mar ’24 | UK£0.26 | UK£0.35 +36.7% | 14.3% | UK£0.40 | UK£0.30 | UK£0.89 | 2 |
Feb ’24 | UK£0.23 | UK£0.35 +52.2% | 14.3% | UK£0.40 | UK£0.30 | UK£0.71 | 2 |
Jan ’24 | n/a | UK£0.35 0% | 14.3% | UK£0.40 | UK£0.30 | UK£0.80 | 2 |
Dec ’23 | UK£0.21 | UK£0.35 +69.1% | 14.3% | UK£0.40 | UK£0.30 | UK£0.71 | 2 |
Nov ’23 | UK£0.23 | UK£0.35 +51.5% | 14.3% | UK£0.40 | UK£0.30 | UK£0.42 | 2 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.
Discover undervalued companies
Ontex Group
€603.7m
Develops, produces, and supplies personal hygiene products and solutions for baby, feminine, and adult care in Belgium, the United Kingdom, the United States, Italy, France, and internationally.
0QVQ
€7.44
7D
-2.1%
1Y
5.6%
Accrol Group Holdings
UK£123.7m
Engages in the soft tissue paper converting business in the United Kingdom and Europe.
ACRL
UK£0.39
7D
0%
1Y
9.6%
Suominen Oyj
€174.5m
Manufactures and sells nonwovens as roll goods for wipes and other applications in Finland, the Americas, the rest of Europe, and internationally.
0M1M
€2.65
7D
0%
1Y
-47.8%